Cost–effectiveness of switching from tenofovir disoproxil fumarate to tenofovir alafenamide versus entecavir for chronic hepatitis B patients in Greece
Article in Journal of Comparative Effectiveness Research (February 2024)
The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.
A real-world retrospective single-centre study of the cost-effectiveness and long-term outcomes of pegylated interferon for chronic hepatitis B
Article in Canadian Liver Journal (October 2023)
Early Treatment Consideration in Patients with Hepatitis B ‘e’ Antigen-Positive Chronic Infection: Is It Time for a Paradigm Shift?
Article in Viruses (April 2022)